Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Better prospects for diagnostic test reimbursement in Germany

This article was originally published in Clinica

Executive Summary

Germany's diagnostics industry association (VDGH) has welcomed the recently-expressed view of the federal government that the inclusion of medical procedures in the reimbursement catalogue of the statutory sickness funds (GKV) should be simpler and more transparent. "Should this sentiment become a hard-and-fast decision, there would be hope that new lab tests will also, finally, be made available to those with sickness insurance," said the Frankfurt-based association's chairman, Volker Oeding.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT052874

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel